You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.


Covid-19 Resource Center
Select region

Flixene Vascular Grafts

ePTFE Vascular Grafts

Flixene provides a durable vascular access option.

Premium performance for dialysis access

Flixene is a unique 3 layer ePTFE graft designed for use in both vascular bypass and AV Access graft applications. The 3 layer construction provides Flixene significantly improved strength and durability over previous Getinge single and double layer ePTFE grafts. To address a broad number of patient needs, Flixene grafts are offered in a variety of configurations including:

A choice of configuration


Getinge offers an extensive line of straight grafts.  Straight grafts are often used for those applications where a bypass is needed and vessel diameter remains a constant from the proximal to the distal anastomosis.
This configuration is offered in both graduated wall and standard wall thickness.


A wide selection of tapered grafts is also offered for those clinical applications where flow dynamics need to be altered or when performing a bypass between two different diameter vessels. [1]
Configuration available in both graduated wall and standard wall thickness.

Graduated Wall (GW)

To offer physicians improved suturability and handling, the Flixene GW grafts offer a reduced wall thickness at the proximal and distal 8cm segments of the graft. Getinge’s engineers were able to achieve this without reducing the strength and durability of the Flixene GW in comparison to that of our standard wall grafts which remain an active part of our portfolio. [1]

Standard Wall (SW)

Getinge also offers a full line of standard wall thickness grafts.

Flixene offers a strong and durable cannulation zone engineered to meet the clinical demands for dialysis access. [1]

Clinical data demonstrates the ability of Flixene to be safely cannulated within 24 to 72 hours, enabling patients to begin dialysis within days rather than weeks. [2]

Flixene comes equipped with the SLIDER GDS tunneling system. Use of the SLIDER GDS has been associated with reduced complication (seroma and pseudoaneurysm formation) as well as reduced soft tissue trauma occurrence during the tunneling process. [3]

Flixene has an average outer surface porosity of 60µm, and an average inner surface porosity of 20µm. [1]

  • Learn more about the Flixene AV access graft. Flixene includes a slider GDS system with plastic sheath for easy tunneling, reduced soft tissue trauma and targeted placement. Flixene is shown to be a viable option for early cannulation within 3 days, reducing the need and risks associated with CVCs for patients

  • Proper cannulation practices are essential to minimizing complications and maintaining a viable access. We are pleased to provide this pocket guide based on the KDOQI and ESVS vascular access guidelines. The intention of this guide is to highlight best practices for arteriovenous graft cannulation to improve quality of patient care.

Improve your knowledge with our eLearning and training courses

At Getinge Educational Institute, we have dedicated material for topics related to Intensive Care, Cardiovascular Procedures, Peripheral Vascular Surgery, Thoracic Vascular Surgery, and Arteriovenous Access, Operating Room and Sterile Processing. We can support you with information about current technologies and best practices to boost your performance and productivity.

For more information about our onsite events or remote trainings, you can also contact your local sales & service representative.

  1. 1. Data on file

  2. 2. Schild AF, Schuman ES, Noicely K, et al. Early cannulation prosthetic graft (Flixene) for arteriovenous access. J Vasc Access. 2011 Jul-Sep;12(3):248-52.

  3. 3. Schild AF, Baltodano NM, Alfieri K, Livingstone J, Raines JK. New Graft for Low Friction Tunneling in Vascular Access Surgery. J Vasc Access. 2004 Jan-Mar;5(1):19-24.